Company / CapEx per Share
Immunovant, Inc. CapEx per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2024
5-year range
$0.00 / $0.01
FY2020-FY2024
Trend
+92.1%
vs FY2023
Sector context
#141 of 190
Health Care
What the data says
At $0.01, Immunovant, Inc.'s capex per share ranks #141 of 190 in the Health Care sector. CapEx per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2019 to $0.01 in FY2024.
Based on SEC 10-K filings.
0.01 in FY2024 with a 5-year CAGR of +47.5%.
Improved from $0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +29.3%
- 5-Year CAGR
- +47.5%
- 10-Year CAGR
- -
Sector benchmark
#141 of 190 in Health CareTop 74% of 190This company $0.01 Sector average $2.49
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2024, capex per share increased 92.1% year-over-year.
- Ranks #141 out of 190 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.01 | +92.1% |
| FY2023 | $0.00 | +62.9% |
| FY2022 | $0.00 | -30.9% |
| FY2021 | $0.00 | -3.2% |
| FY2020 | $0.00 | +233.5% |
| FY2019 | $0.00 | -69.4% |
| FY2018 | $0.00 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026